MPP Strategy 2023 -2025

The Medicines Patent Pool (MPP) Strategy for 2023-2025 outlines a comprehensive plan to enhance global health by ensuring that people in low- and middle-income countries (LMICs) have rapid access to effective and affordable medical treatments and health technologies. The strategy is driven by five key goals:

1. Expand access to innovative medicines for infectious diseases, including HIV, TB, and Viral Hepatitis.
2. Establish voluntary licensing as an impactful access mechanism for a broader range of diseases and conditions, including non-communicable diseases (NCDs), maternal health, and pediatric needs.
3. Facilitate the development and access to novel medical technologies, such as long-acting biologics and mRNA vaccines.
4. Accelerate equitable access to countermeasures for pandemics and other international health emergencies like COVID-19.
5. Support the diversification and sustainability of manufacturing capacities, including local and regional production, through technology transfer